ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2108964
CHEMBL2108964
Compound Name INSULIN, ISOPHANE
ChEMBL Synonyms INS INSUMAN BASAL OPTISET | INSULIN, ISOPHANE | INS PUR-IN HUM ISOP | INS NOVOLET HUM PROTAPHANE | INS HYPURIN BOV ISOP | ISOPHANE INSULIN | INS INSUMAN BASAL | INS INNOLET INSULAT | NPH | INS HUM PROTAPHANE | INS HYPURIN PORE ISOP | INS HUMULIN I | INSULIN INJECTION | NPH ILETIN | ISOPHANE (AQUEOUS SUSPENSION) | INS INSULAT | INS HUM INSULAT | PENFILL | INS PORK INSULAT | INS INSUMAN BASAL SOLOSTAR | INS INSULAT NOVOLET
Max Phase 4 (Approved)
Trade Names INS INSUMAN BASAL OPTISET | INS INNOLET INSULAT | INS INSUMAN BASAL | INS HYPURIN BOV ISOP | INS NOVOLET HUM PROTAPHANE | INS PUR-IN HUM ISOP | NPH ILETIN | INS HUMULIN I | INS HYPURIN PORE ISOP | INS HUM PROTAPHANE | NPH | INS INSULAT NOVOLET | INS INSUMAN BASAL SOLOSTAR | INS PORK INSULAT | PENFILL | INS HUM INSULAT | INS INSULAT

Sources

  • British National Formulary
  • USP Dictionary of USAN and International Drug Names

Molecule Features

CHEMBL2108964 compound icon
Drug Type:Oligopeptide Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:N Topical:N Black Box:N Availability Type:Unknown

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Diabetes Mellitus, Type 1D003922EFO:0001359type I diabetes mellitus3ClinicalTrials
Diabetes MellitusD003920EFO:0000400diabetes mellitus1ClinicalTrials
Diabetes Mellitus, Type 2D003924EFO:0001360type II diabetes mellitus1ClinicalTrials

Clinical Data

ClinicalTrials.gov INSULIN, ISOPHANE
The Cochrane Collaboration INSULIN, ISOPHANE

Compound Cross References

ChemSpider ChemSpider Identifier not yet assigned
spacer
spacer